直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

AbbVie Inc. v. Sandoz Inc.

AbbVie Inc.

Sandoz Inc.

Represented AbbVie in Biologics Price Competition and Innovation (BPCIA) litigation related to Humira®.

AbbVie Inc. v. Sandoz Inc., 3:18-cv-12668, D.N.J., Judge Wolfson

Related Professionals

William B. Raich, Ph.D.
Partner
Washington, DC
+1 202 408 4210
Email

Related Experiences

Sandoz Inc. v. AbbVie Biotechnology, Ltd

AbbVie Biotechnology, Ltd

Finnegan client AbbVie secures non-institution decisions for Humira® patents

AbbVie Biotechnology, Ltd

Multiple settlement and license agreements for AbbVie, Inc.

AbbVie, Inc.

AbbVie Inc. v. Hospira, Inc. 

AbbVie Inc.

AbbVie Inc. v. Matrix Labs

AbbVie Inc.

AbbVie Inc. v. Roxane Laboratories Inc.

AbbVie Inc.

AbbVie Inc., et al. v. Aurobindo Pharma U.S.A., Inc. et al.

AbbVie Inc.

AbbVie Inc. et al v. Alvotech hf.

AbbVie Inc. et al

AbbVie Inc. v. Amgen Inc.

AbbVie Inc.

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP